Antibody-Mediated Rejection of Cardiac Allografts in CCR5-Deficient Recipients
Authors:
- 15 October 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 179 (8) , 5238-5245
Abstract
Rejected MHC-mismatched cardiac allografts in CCR5−/− recipients have low T cell infiltration, but intense deposition of C3d in the large vessels and capillaries of the graft, characteristics of Ab-mediated rejection. The roles of donor-specific Ab and CD4 and CD8 T cell responses in the rejection of complete MHC-mismatched heart grafts by CCR5−/− recipients were directly investigated. Wild-type C57BL/6 and B6.CCR5−/− (H-2b) recipients of A/J (H-2a) cardiac allografts had equivalent numbers of donor-reactive CD4 T cells producing IFN-γ, whereas CD4 T cells producing IL-4 were increased in CCR5−/− recipients. Numbers of donor-reactive CD8 T cells producing IFN-γ were reduced 60% in CCR5−/− recipients. Day 8 posttransplant serum titers of donor-specific Ab were 15- to 25-fold higher in CCR5−/− allograft recipients, and transfer of this serum provoked cardiac allograft rejection in RAG-1−/− recipients within 14 days, whereas transfer of either serum from wild-type recipients or immune serum from CCR5-deficient recipients diluted to titers observed in wild-type recipients did not mediate this rejection. Wild-type C57BL/6 and B6.CCR5−/− recipients rejected A/J cardiac grafts by day 11, whereas rejection was delayed (day 12–60, mean 21 days) in μMT−/−/CCR5−/− recipients. These results indicate that the donor-specific Ab produced in CCR5−/− heart allograft recipients is sufficient to directly mediate graft rejection, and the absence of recipient CCR5 expression has differential effects on the priming of alloreactive CD4 and CD8 T cells.Keywords
This publication has 41 references indexed in Scilit:
- CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistenceJournal of Experimental Medicine, 2006
- Inhibition of Polymorphonuclear Leukocyte–Mediated Graft Damage Synergizes With Short-Term Costimulatory Blockade to Prevent Cardiac Allograft RejectionCirculation, 2005
- Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non‐obese diabetic miceEuropean Journal of Immunology, 2004
- CONTRIBUTION OF DONOR-SPECIFIC ANTIBODIES TO ACUTE ALLOGRAFT REJECTIONTransplantation, 1998
- EVIDENCE DEMONSTRATING POOR KIDNEY GRAFT SURVIVAL WHEN ACUTE REJECTIONS ARE ASSOCIATED WITH IgG DONOR-SPECIFIC LYMPHOCYTOTOXINTransplantation, 1995
- The Contribution Of Terminal Complement Components To Acute And Hyperacute Allograft Rejection In The RatTransplantation, 1995
- Tolerance in the mouse to major histocompatibility complex‐mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8European Journal of Immunology, 1992
- CELLS MEDIATING ALLOGRAFT REJECTIONTransplantation, 1991
- RESISTANCE TO GRAFT-VERSUS-HOST DISEASE FOLLOWING SMALL BOWEL TRANSPLANTATIONTransplantation, 1991
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984